Can I Take Folate with Finasteride?

How Finasteride Works and Why Folate Doesn't Interfere

Finasteride selectively inhibits the type II isoenzyme of 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). At 1 mg daily for androgenetic alopecia, finasteride reduces scalp DHT concentrations by roughly 64% and serum DHT by about 71% [1]. The drug is metabolized hepatically via cytochrome P450 3A4, with no involvement of folate-dependent methylation pathways [2].

Finasteride's Metabolic Pathway

Finasteride undergoes extensive first-pass hepatic metabolism. CYP3A4 is the primary enzyme responsible, producing two inactive metabolites that are excreted in urine and feces. This metabolic route is entirely separate from the one-carbon cycle that folate feeds into. No competitive inhibition, enzyme induction, or transporter-level conflict has been documented between finasteride and any folate vitamer.

Folate's Metabolic Pathway

Folate (vitamin B9) enters the one-carbon metabolism cycle after intestinal absorption and hepatic reduction. Synthetic folic acid requires conversion by dihydrofolate reductase (DHFR) to tetrahydrofolate, then to 5-methyltetrahydrofolate (5-MTHF) via the MTHFR enzyme [3]. This entire sequence operates independently of steroid hormone metabolism and cytochrome P450 3A4 activity.

No Overlapping Enzyme or Transporter Competition

Because finasteride relies on CYP3A4 and folate relies on DHFR and MTHFR, the two compounds do not compete for the same enzymatic machinery. Folate absorption occurs via proton-coupled folate transporters (PCFT) and reduced folate carriers (RFC) in the jejunum [3]. Finasteride absorption is passive and near-complete. There is no shared transporter.

What the Evidence Actually Shows

No published randomized controlled trial, case report, or pharmacokinetic interaction study has identified a clinically meaningful interaction between finasteride and folate in any form. A PubMed search combining "finasteride" with "folate," "folic acid," or "methylfolate" returns zero interaction studies as of May 2026.

Database Cross-References

The Natural Medicines Comprehensive Database, which grades supplement-drug interactions on a five-tier severity scale, does not list folate as interacting with finasteride at any severity level [4]. The Mayo Clinic drug interaction checker similarly returns no interaction result for this combination. Lexicomp and Micromedex, the two most widely used clinical pharmacology databases in U.S. Hospital systems, contain no monograph entries for a finasteride-folate interaction.

Why the Absence of Data Is Informative

In pharmacology, the absence of interaction data for two widely used compounds is itself meaningful. Finasteride has been prescribed since 1992 (Proscar for BPH) and 1997 (Propecia for hair loss). Folate supplementation is among the most common vitamin interventions worldwide, taken by an estimated 35% of U.S. Adults who use dietary supplements [5]. If a clinically significant interaction existed, pharmacovigilance databases such as the FDA Adverse Event Reporting System (FAERS) would almost certainly have flagged it over three decades of co-prescribing.

MTHFR Variants: What Finasteride Users Should Know

The MTHFR gene encodes the enzyme methylenetetrahydrofolate reductase, which converts 5,10-methylenetetrahydrofolate to 5-MTHF. Two common single-nucleotide polymorphisms affect enzyme activity: C677T and A1298C.

C677T Homozygosity

Individuals homozygous for C677T (TT genotype) have approximately 70% reduced MTHFR enzyme activity compared to the CC wildtype [6]. This means synthetic folic acid is converted to its active 5-MTHF form less efficiently. The TT genotype occurs in roughly 10 to 15% of European-descent populations and up to 25% of some Hispanic populations [6].

Practical Implications for Finasteride Users

MTHFR status does not change the safety of combining folate with finasteride. It does, however, influence which form of folate is optimal. For TT homozygotes, L-methylfolate (5-MTHF) bypasses the impaired MTHFR step entirely. This is a folate-specific decision, not a finasteride-specific one. Whether or not you take finasteride, the recommendation for MTHFR TT carriers is the same: consider 400 to 800 mcg of L-methylfolate rather than synthetic folic acid [7].

When MTHFR Testing Makes Sense

Routine MTHFR testing is not recommended by the American College of Medical Genetics (ACMG) for the general population [8]. Testing may be reasonable if you have unexplained hyperhomocysteinemia (homocysteine above 15 micromol/L), a personal or family history of neural tube defects, or recurrent pregnancy loss. A finasteride prescription alone is not an indication for MTHFR genotyping.

Folate's Independent Role in Hair Health

Folate contributes to DNA synthesis and cell division, processes that are active in the hair follicle during the anagen (growth) phase. Some clinicians recommend folate as part of a broader nutritional support strategy alongside finasteride, though the evidence for folate supplementation specifically improving hair density is limited.

What the Data Supports

A 2017 cross-sectional study of 115 patients with telogen effluvium found that serum folate levels were significantly lower in affected patients compared to healthy controls (mean 8.4 vs. 12.1 ng/mL, P = 0.003) [9]. This association does not prove causation, and telogen effluvium is a mechanistically distinct condition from androgenetic alopecia.

What the Data Does Not Support

No RCT has demonstrated that folate supplementation enhances finasteride's efficacy for male-pattern hair loss. The Prostate Cancer Prevention Trial (PCPT, N = 18,882) used finasteride 5 mg daily and tracked numerous biomarkers over seven years, but did not assess folate co-supplementation as a variable [10]. Claims that folate "boosts" finasteride's hair-regrowth effects remain unsupported by controlled data.

Reasonable Supplementation Strategy

If your dietary folate intake is below the RDA of 400 mcg DFE (dietary folate equivalents) per day, supplementation makes sense for general health reasons. Green leafy vegetables, legumes, and fortified grains are the primary dietary sources. For men taking finasteride for hair loss, ensuring adequate folate status is reasonable but should not be framed as a finasteride-specific intervention.

Dosing, Timing, and Practical Guidance

Because no interaction exists, co-administration logistics are straightforward.

Recommended Doses

Finasteride for androgenetic alopecia: 1 mg oral daily. Finasteride for BPH: 5 mg oral daily. Folate for general adult maintenance: 400 mcg DFE daily. Folate upper tolerable intake (synthetic folic acid): 1,000 mcg daily per the Institute of Medicine [11]. This upper limit applies to synthetic folic acid only, not to dietary folate or L-methylfolate, which have no established UL.

Timing

Take both at whatever time fits your routine. Morning, evening, with or without food. Finasteride absorption is not affected by food. Folic acid absorption is marginally higher on an empty stomach, but the clinical difference is negligible at supplemental doses [3]. No separation window is needed.

What About High-Dose Folate?

Some protocols use 5 to 15 mg of L-methylfolate daily for treatment-resistant depression (adjunctive to SSRIs) under the brand name Deplin. Even at these supraphysiologic doses, no interaction with finasteride has been reported. If your prescriber has recommended high-dose methylfolate for a psychiatric indication, finasteride does not need to be adjusted.

Monitoring Recommendations

Routine monitoring specifically for this combination is not necessary. Standard clinical practice applies.

For Finasteride

Baseline and periodic PSA measurement if taking finasteride 5 mg for BPH, because finasteride reduces PSA values by approximately 50%, which must be accounted for in prostate cancer screening [10]. For men on 1 mg for hair loss, PSA monitoring is guided by age-appropriate screening guidelines (USPSTF recommends shared decision-making for men aged 55 to 69) [12].

For Folate

Serum folate and homocysteine levels may be checked if there is clinical suspicion of deficiency (macrocytic anemia, elevated MCV on CBC, neuropathy symptoms). The normal serum folate range is generally 3 to 20 ng/mL. Homocysteine above 15 micromol/L may suggest functional folate (or B12) insufficiency.

Red Flags That Warrant Clinician Contact

New-onset macrocytic anemia (MCV above 100 fL) in a patient taking folate could indicate masked B12 deficiency. Folate supplementation can correct the hematologic manifestation of B12 deficiency while allowing neurological damage to progress. This concern is unrelated to finasteride but is clinically important for anyone supplementing folate at doses above 400 mcg daily [11].

Drug Interactions That Actually Matter with Finasteride

While folate is not a concern, several compounds do interact with finasteride through CYP3A4-mediated pathways.

CYP3A4 Inhibitors

Strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin) can theoretically increase finasteride plasma concentrations. The clinical significance at the 1 mg hair-loss dose is considered minimal because of finasteride's wide therapeutic index, but clinicians should be aware of the interaction at the 5 mg BPH dose [2].

St. John's Wort

St. John's wort (Hypericum perforatum) is a potent CYP3A4 inducer and could reduce finasteride efficacy by accelerating its metabolism. This is a supplement interaction that does warrant clinical attention, unlike folate [13].

Alpha-Blockers

For BPH patients, co-prescribing finasteride with alpha-blockers (tamsulosin, doxazosin) is a well-established combination therapy studied in the MTOPS trial (N = 3,047). The combination reduced clinical progression of BPH by 66% compared to placebo over 4.5 years [14]. This is not an adverse interaction but rather an intentional synergistic pairing.

What to Do If You're Already Taking Both

Nothing needs to change. Continue both at your current doses and schedules. There is no pharmacological reason to separate doses, discontinue either compound, or add monitoring beyond what each medication independently requires.

If you are taking synthetic folic acid and have confirmed MTHFR C677T homozygosity, consider switching to L-methylfolate. This recommendation stands regardless of finasteride use. Discuss the switch with your prescriber, especially if folate was prescribed for a specific clinical indication such as pregnancy planning or hyperhomocysteinemia management.

The 2024 Endocrine Society clinical practice guideline on androgen therapy does not list folate or any B vitamin among substances requiring dose adjustment or avoidance with 5-alpha reductase inhibitors [15].